InsuSense Therapeutics is a product-focused biotechnology company working on different natural circulating and cellular proteins from the sortilin (Vps10p) family.
InsuSense Therapeutics Goals & Strategy
IST’s vision is to bring forward novel therapeutics, based on unique scientific understanding and intellectual property of the company, offering patients superior treatment options.
IST is currently pursuing this by with Vps10p mechanisms of action.